Screener
Indivior Pharmaceuticals, Inc. INDV PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Other current assets | 40 | 16 |
| Total current assets | 667 | 652 |
| Long-term investments | 27 | 28 |
| Property, plant and equipment, net | 157 | 144 |
| Operating lease right of use assets, net | 22 | 26 |
| Goodwill and other intangible assets, net | 2 | 2 |
| Deferred tax assets | 296 | 323 |
| Other noncurrent assets | 26 | 27 |
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s PP&E (net)?
- Indivior Pharmaceuticals, Inc. (INDV) reported PP&E (net) of $157M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s PP&E (net) increased by 51.0% year-over-year, from $104M to $157M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s PP&E (net)?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s PP&E (net) has grown at a 30.9% compound annual growth rate (CAGR), from $84M to $144M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Indivior Pharmaceuticals, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude